Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Ketoconazole lotion can improve hair regrowth for some people with androgenetic alopecia.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Hair growth and health are influenced by stress and hormones.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Smoking increases early hair loss risk in men; quitting may help prevent it.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Finasteride is effective and safe.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.